248 related articles for article (PubMed ID: 20528766)
1. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications.
Toledano A; Alvarez MI; Toledano-Díaz A
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.
Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD
Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective and neurotoxic effects of nicotine.
Ferrea S; Winterer G
Pharmacopsychiatry; 2009 Nov; 42(6):255-65. PubMed ID: 19924585
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic receptor subtypes and cognitive function.
Levin ED
J Neurobiol; 2002 Dec; 53(4):633-40. PubMed ID: 12436426
[TBL] [Abstract][Full Text] [Related]
5. Development of nicotinic drug therapy for cognitive disorders.
Levin ED; Rezvani AH
Eur J Pharmacol; 2000 Mar; 393(1-3):141-6. PubMed ID: 10771007
[TBL] [Abstract][Full Text] [Related]
6. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.
Mihailescu S; Drucker-Colín R
Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.
Mudo G; Belluardo N; Fuxe K
J Neural Transm (Vienna); 2007 Jan; 114(1):135-47. PubMed ID: 16906354
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic systems and cognitive function.
Levin ED
Psychopharmacology (Berl); 1992; 108(4):417-31. PubMed ID: 1357713
[TBL] [Abstract][Full Text] [Related]
9. The benefits and drawbacks of nicotine exposure in the cortex and hippocampus of old rats.
Barros DM; Galhardi FG; Ribas Ferreira JL; Guterres LB; Dickel O; Geracitano LA; Izquierdo I; Monserrat JM
Neurotoxicology; 2007 May; 28(3):562-8. PubMed ID: 17350101
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function.
Levin ED; Hall BJ; Rezvani AH
Curr Top Behav Neurosci; 2015; 23():87-101. PubMed ID: 25655888
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic alteration of decision-making.
Naudé J; Dongelmans M; Faure P
Neuropharmacology; 2015 Sep; 96(Pt B):244-54. PubMed ID: 25498234
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic acetylcholine involvement in cognitive function in animals.
Levin ED; Simon BB
Psychopharmacology (Berl); 1998 Aug; 138(3-4):217-30. PubMed ID: 9725745
[TBL] [Abstract][Full Text] [Related]
13. New mechanisms and perspectives in nicotine withdrawal.
Jackson KJ; Muldoon PP; De Biasi M; Damaj MI
Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
Levin ED; McClernon FJ; Rezvani AH
Psychopharmacology (Berl); 2006 Mar; 184(3-4):523-39. PubMed ID: 16220335
[TBL] [Abstract][Full Text] [Related]
15. Synaptic plasticity and nicotine addiction.
Dani JA; Ji D; Zhou FM
Neuron; 2001 Aug; 31(3):349-52. PubMed ID: 11516393
[TBL] [Abstract][Full Text] [Related]
16. Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and Krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain.
Turégano L; Martínez-Rodríguez R; Alvarez MI; Gragera RR; Gómez de Segura A; De Miguel E; Toledano A
J Neurosci Res; 2001 Jun; 64(6):626-35. PubMed ID: 11398187
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function.
Cannady R; Weir R; Wee B; Gotschlich E; Kolia N; Lau E; Brotherton J; Levin ED
Biochem Pharmacol; 2009 Oct; 78(7):788-94. PubMed ID: 19477167
[TBL] [Abstract][Full Text] [Related]
18. The nicotinic cholinergic system function in the human brain.
Nees F
Neuropharmacology; 2015 Sep; 96(Pt B):289-301. PubMed ID: 25446570
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
Newhouse PA; Potter A; Levin ED
Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
[TBL] [Abstract][Full Text] [Related]
20. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
